参考文献:
[1]DORING G,MEISNER C,STERN M,et al.A doubleblind randomized placebocontrolled phase Ⅲ study of a Pseudomonas aeruginosa flagella vaccine in cystic fibrosis patients [J].Proceedings of the National Academy of Sciences of the United States of America,2007,104(26):11020-11025.
[2]DORING G,PIER G B.Vaccines and immunotherapy against Pseudomonas aeruginosa[J].Vaccine,2008,26(8):1011-1024.
[3]ZHAO Y,GUO L,LI J,et al.Molecular epidemiology,antimicrobial susceptibility,and pulsedfield gel electrophoresis genotyping of Pseudomonas aeruginosa isolates from mink[J].Canadian Journal of Veterinary Research,2018,82(4):256-263.
[4]NIKOLAISEN N K,LASSEN D K,CHRIE M,et al.Antimicrobial resistance among pathogenic bacteria from mink (Neovison vison) in Denmark[J].Acta Veterinaria Scandinavica,2017,59(1):60.
[5]ZHANG M L,SUN C J,GU J M,et al.Salmonella Typhimurium strain expressing OprFOprI protects mice against fatal infection by Pseudomonas aeruginosa[J].Microbiology and Immunolgy,2015,59(9):533-544.
[6]KNOX B.Pseudomonas aeruginosa som arsag til enzootiske infektioner hos mink[J].Nordisk Veterinaer Medicin,1953:731760.
[7]JING Q,LI L,DU Y,et al.The identification,typing,and antimicrobial susceptibility of Pseudomonas aeruginosaisolated from mink with hemorrhagic pneumonia[J].Veterinary Microbiology,2014,170(3):456-461.
[8]国家标准化管理委员会.实验动物 绿脓杆菌检测方法 GB/T 14926.17—2001[S].北京:中国标准出版社,2001:63-65.
[9]美国临床和实验室标准协会.抗菌药物敏感性试验执行标准[J].中国检验医学杂志,2012,32(3):20-179.
[10]SARLANGUE J,BRISSAUD O,LABREZE C.Clinical features of Pseudomonas aeruginosa infections[J].Archives de Pédiatrie,2006,13(S1):S13-6.
[11]WU W H,HUANG J,DUAN B Y,et al.Th17stimulating protein vaccines confer protection against Pseudomonas aeruginosa pneumonia[J].American Journal of Respiratory and Critical Care Medicine,2012,186(5):420-427.
[12]DING B,VON SPECHT B U,LI Y Y.OprF/Ivaccinated sera inhibit binding of human interferongamma to Pseudomonas aeruginosa[J].Vaccine,2010,28(25):4119-4122.
[13]HARIHARAN H,COLES M,POOLE D,et al.Update on antimicrobial susceptibilities of bacterial isolates from canine and feline otitis externa[J].Canadian Veterinary Journalrevue Veterinaire Canadienne,2006,47(3):253-255.
[14]JENSEN V F,SOMMER H M,STRUVE T,et al.Factors associated with usage of antimicrobials in commercial mink(Neovison vison)production in Denmark[J].Preventive Veterinary Medicine,2016,126:170-182.
[15]张明亮,闫新武,孙长江,等.铜绿假单胞菌F190—342-I21—83基因的克隆及其融合蛋白的原核表达[J].河南农业科学,2018,47(12):132-136,150.
[16]TAM V H,CHANG K.Prevalence,resistance mechanisms,and susceptibility of multidrugresistant bloodstream isolates of Pseudomonas aeruginosa[J].Antimicrobial Agents and Chemotherapy,2010,54(3):1160-1164.
[17]KHAJURIA A,PRAHARAJ A K,Kumar M,et al.Emergence of NDM1 in the clinical isolates of Pseudomonas aeruginosa in India[J].Journal of Clinical & Diagnostic Research Jcdr,2013,7(7):1328-1331.
[18]MARTINO P,MARTINO J J,VILLAR J A.Hemorrhagic pneumonia caused by Pseudomonas aeruginosa in mink in Argentina[J].Revista Argentina De Microbiologia,1985,17(3):145-148. [19]SALOMONSEN C M,THEMUDO G E,JELSBAK L,et al.Typing of Pseudomonas aeruginosa from hemorrhagic pneumonia in mink(Neovison vison)[J].Veterinary Microbiology,2013,163(1/2):103-109.
[20]CUKOR G,NOWAK N A.Affinity chromatography purification of Pseudomonas aeruginosa exotoxin A on specifically linked NAD agarose[J].Journal of Bacteriology,1982,149(3):1162-1165.[21]SALOMONSEN C M,CHRIEL M,JENSEN T H,et al.Effect of infectious dose and season on development of hemorrhagic pneumonia in mink caused by Pseudomonas aeruginosa[J].Canadian Journal of Veterinary Research,2013,77(3):221-225. |